{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T09:12:44Z","timestamp":1775898764184,"version":"3.50.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ejso.2022.04.020","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T02:27:20Z","timestamp":1651890440000},"page":"1068-1080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["How to treat liposarcomas located in retroperitoneum"],"prefix":"10.1016","volume":"49","author":[{"given":"Maria","family":"Danieli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol J.","family":"Swallow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4703-3534","authenticated-orcid":false,"given":"Alessandro","family":"Gronchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejso.2022.04.020_bib1","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/annonc\/mdz124","article-title":"NETSARC\/REPPS\/RESOS and French Sarcoma Group\u2013Groupe d'Etude des Tumeurs Osseuses (GSF-GETO) Networks. Surgery in reference centers improves survival of sarcoma patients: a nationwide study","volume":"30","author":"Blay","year":"2019","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2022.04.020_bib2","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/annonc\/mdz408","article-title":"Criteria for reference centers for sarcomas: volume but also long-term multidisciplinary organisation","volume":"30","author":"Blay","year":"2019","journal-title":"Ann Oncol"},{"issue":"23","key":"10.1016\/j.ejso.2022.04.020_bib3","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1002\/cncr.31749","article-title":"A\u00a0call to action: Why sarcoma surgery needs to be centralized","volume":"124","author":"Raut","year":"2018","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ejso.2022.04.020_bib4","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1245\/s10434-019-07421-9","article-title":"Survival benefit of the surgical management of retroperitoneal sarcoma in a reference center: a nationwide study of the French sarcoma group from the NetSarc database","volume":"26","author":"Bonvalot","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"23","key":"10.1016\/j.ejso.2022.04.020_bib5","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1002\/cncr.31750","article-title":"Is surgery for retroperitoneal sarcoma at \"low-volume\" hospitals a bad idea?","volume":"124","author":"Putt","year":"2018","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2022.04.020_bib6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/annonc\/mdt577","article-title":"Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group","volume":"25","author":"Toulmonde","year":"2014","journal-title":"Ann Oncol"},{"issue":"23","key":"10.1016\/j.ejso.2022.04.020_bib7","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1002\/cncr.31699","article-title":"Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma","volume":"124","author":"Keung","year":"2018","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ejso.2022.04.020_bib8","doi-asserted-by":"crossref","first-page":"e991","DOI":"10.1200\/JOP.19.00460","article-title":"Variations in retroperitoneal soft tissue sarcoma outcomes by hospital type: a National cancer database analysis","volume":"16","author":"Villano","year":"2020","journal-title":"JCO Oncol Pract"},{"issue":"13","key":"10.1016\/j.ejso.2022.04.020_bib9","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1200\/JCO.2012.44.3747","article-title":"Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets","volume":"31","author":"Gronchi","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2022.04.020_bib10","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(16)00010-3","article-title":"Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis","volume":"17","author":"Callegaro","year":"2016","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2022.04.020_bib11","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/SLA.0000000000001447","article-title":"Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1007 patients from the multi-institutional collaborative RPS working group","volume":"263","author":"Gronchi","year":"2016","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.ejso.2022.04.020_bib12","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1158\/1078-0432.CCR-18-2700","article-title":"Predicting survival in patients undergoing resection for locally recurrent retroperitoneal sarcoma: a study and novel nomogram from TARPSWG","volume":"25","author":"Raut","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.ejso.2022.04.020_bib13","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S1470-2045(20)30446-0","article-title":"Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial","volume":"21","author":"Bonvalot","year":"2020","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2022.04.020_bib14","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/CCO.0000000000000535","article-title":"New research strategies in retroperitoneal sarcoma. The case of TARPSWG, STRASS and RESAR: making progress through collaboration","volume":"31","author":"van Houdt","year":"2019","journal-title":"Curr Opin Oncol"},{"issue":"13","key":"10.1016\/j.ejso.2022.04.020_bib15","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1245\/s10434-016-5538-z","article-title":"The trans-atlantic retroperitoneal sarcoma working group (TARPSWG): \"red wine or white","volume":"23","author":"Tseng","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2022.04.020_bib16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1245\/s10434-014-3965-2","article-title":"Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group","volume":"22","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2022.04.020_bib17","doi-asserted-by":"crossref","first-page":"7873","DOI":"10.1245\/s10434-021-09654-z","article-title":"Management of primary retroperitoneal sarcoma (RPS) in the adult: an updated consensus approach from the transatlantic Australasian RPS working group","volume":"28","author":"Swallow","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2022.04.020_bib18","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1245\/s10434-016-5336-7","article-title":"Management of recurrent retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the trans-atlantic RPS working group","volume":"23","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2022.04.020_bib19","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/annonc\/mdy052","article-title":"Management of metastatic retroperitoneal sarcoma: a consensus approach from the trans-atlantic retroperitoneal sarcoma working group (TARPSWG)","volume":"29","year":"2018","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2022.04.020_bib20","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1245\/s10434-014-4130-7","article-title":"Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resection","volume":"22","author":"Gronchi","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.04.020_bib21","series-title":"NCCN clinical practice guidelines in Oncology: soft tissue sarcoma - version 2.2021","author":"von Mehren","year":"2021"},{"issue":"11","key":"10.1016\/j.ejso.2022.04.020_bib22","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","article-title":"Electronic address: clinical guidelines@esmo.org. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2606","volume":"32","author":"Gronchi","year":"2021","journal-title":"Ann Oncol"},{"issue":"Suppl 4","key":"10.1016\/j.ejso.2022.04.020_bib23","doi-asserted-by":"crossref","first-page":"iv268","DOI":"10.1093\/annonc\/mdy321","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Casali","year":"2018","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2022.04.020_bib24","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1245\/s10434-014-4059-x","article-title":"Percutaneous core needle biopsy in retroperitoneal sarcomas does not influence local recurrence or overall survival","volume":"22","author":"Wilkinson","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2022.04.020_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/modpathol.2008.164","article-title":"Primary retroperitoneal myxoid\/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis","volume":"22","author":"de Vreeze","year":"2009","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.ejso.2022.04.020_bib26","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1245\/s10434-020-08519-1","article-title":"Improved biopsy accuracy in retroperitoneal dedifferentiated liposarcoma","volume":"27","author":"Tirotta","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2022.04.020_bib27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/bjs.11064","article-title":"Diagnostic accuracy of percutaneous biopsy in retroperitoneal sarcoma","volume":"106","author":"Almond","year":"2019","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.ejso.2022.04.020_bib28","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/jso.26379","article-title":"The role of 18 F-FDG PET\/CT in retroperitoneal sarcomas-A multicenter retrospective study","volume":"123","author":"Subramaniam","year":"2021","journal-title":"J\u00a0Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2022.04.020_bib29","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1007\/s00330-015-3654-y","article-title":"Evaluation of several FDG PET parameters for prediction of soft tissue tumour grade at primary diagnosis and recurrence","volume":"25","author":"Fendler","year":"2015","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.ejso.2022.04.020_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ijc.2910330108","article-title":"Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system","volume":"33","author":"Trojani","year":"1984","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2022.04.020_bib31","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/PAS.0000000000000366","article-title":"Myogenic differentiation and histologic grading are major prognostic determinants in retroperitoneal liposarcoma","volume":"39","author":"Gronchi","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.ejso.2022.04.020_bib32","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/SLA.0000000000001149","article-title":"Histology-based classification predicts pattern of recurrence and improves risk stratification in primary retroperitoneal sarcoma","volume":"263","author":"Tan","year":"2016","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ejso.2022.04.020_bib33","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/01.sla.0000086542.11899.38","article-title":"Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma","volume":"238","author":"Singer","year":"2003","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ejso.2022.04.020_bib34","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1245\/s10434-020-09065-6","article-title":"Has the outcome for patients who undergo resection of primary retroperitoneal sarcoma changed over time? A study of time trends during the past 15 years","volume":"28","author":"Callegaro","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2022.04.020_bib35","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1245\/s10434-007-9805-x","article-title":"Resectable well-differentiated versus dedifferentiated liposarcomas: two different diseases possibly requiring different treatment approaches","volume":"15","author":"Lahat","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2022.04.020_bib36","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/cncr.30572","article-title":"Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: a report from the Trans-Atlantic RPS Working Group","volume":"123","author":"MacNeill","year":"2017","journal-title":"Cancer"},{"issue":"22","key":"10.1016\/j.ejso.2022.04.020_bib37","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1002\/cncr.33139","article-title":"Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: a study from TARPSWG","volume":"126","author":"van Houdt","year":"2020","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2022.04.020_bib38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jamcollsurg.2019.09.013","article-title":"Identifying the minimum volume threshold for retroperitoneal soft tissue sarcoma resection: merging National data with consensus expert opinion","volume":"230","author":"Villano","year":"2020","journal-title":"J\u00a0Am Coll Surg"},{"issue":"2","key":"10.1016\/j.ejso.2022.04.020_bib39","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1245\/s10434-020-08789-9","article-title":"Inoperable primary retroperitoneal sarcomas: clinical characteristics and reasons against resection at a single referral institution","volume":"28","author":"Perhavec","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.04.020_bib40","series-title":"Why were non-metastatic primary retroperitoneal sarcoma not resected?","author":"Deanna","year":"2018"},{"issue":"9","key":"10.1016\/j.ejso.2022.04.020_bib41","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1245\/s10434-012-2342-2","article-title":"Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG","volume":"19","author":"Bonvalot","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2022.04.020_bib42","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1245\/s10434-014-3643-4","article-title":"Locoregional disease patterns in well-differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection?","volume":"21","author":"Tseng","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2022.04.020_bib43","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1245\/s10434-019-07615-1","article-title":"Intraperitoneal invasion of retroperitoneal sarcomas: a risk factor for dismal prognosis","volume":"26","author":"Nizri","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2022.04.020_bib44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1200\/JCO.2008.18.0802","article-title":"Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control","volume":"27","author":"Bonvalot","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2022.04.020_bib45","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1002\/cncr.11365","article-title":"Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients","volume":"97","author":"Zagars","year":"2003","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ejso.2022.04.020_bib46","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0959-8049(99)00287-7","article-title":"Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register","volume":"36","author":"Trovik","year":"2000","journal-title":"Eur J Cancer"},{"issue":"20","key":"10.1016\/j.ejso.2022.04.020_bib47","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.2106\/JBJS.L.01149","article-title":"Impact of margin status and local recurrence on soft-tissue sarcoma outcomes","volume":"95","author":"Potter","year":"2013","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"2","key":"10.1016\/j.ejso.2022.04.020_bib48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/1097-0142(20010715)92:2<359::AID-CNCR1331>3.0.CO;2-Y","article-title":"Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group","volume":"92","author":"Stoeckle","year":"2001","journal-title":"Cancer"},{"issue":"153","key":"10.1016\/j.ejso.2022.04.020_bib49","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00003086-198011000-00013","article-title":"A\u00a0system for the surgical staging of musculoskeletal sarcoma","author":"Enneking","year":"1980","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"10.1016\/j.ejso.2022.04.020_bib50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1200\/JCO.2008.17.8871","article-title":"Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients","volume":"27","author":"Gronchi","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2022.04.020_bib51","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/annonc\/mdr323","article-title":"Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas","volume":"23","author":"Gronchi","year":"2012","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2022.04.020_bib52","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1245\/s10434-010-1057-5","article-title":"Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control","volume":"17","author":"Bonvalot","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2022.04.020_bib53","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1302\/0301-620X.83B8.0831149","article-title":"Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence","volume":"83","author":"Gerrand","year":"2001","journal-title":"J\u00a0Bone Joint Surg Br"},{"issue":"18","key":"10.1016\/j.ejso.2022.04.020_bib54","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1002\/cncr.28793","article-title":"The effect of the setting of a positive surgical margin in soft tissue sarcoma","volume":"120","author":"O'Donnell","year":"2014","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2022.04.020_bib55","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/SLA.0000000000002250","article-title":"Postoperative morbidity after radical resection of primary retroperitoneal sarcoma: a report from the transatlantic RPS working group","volume":"267","author":"MacNeill","year":"2018","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.ejso.2022.04.020_bib56","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/bjs.9829","article-title":"Long-term morbidity after multivisceral resection for retroperitoneal sarcoma","volume":"102","author":"Callegaro","year":"2015","journal-title":"Br J Surg"},{"issue":"7","key":"10.1016\/j.ejso.2022.04.020_bib57","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1245\/s10434-020-09307-7","article-title":"A\u00a0prospective observational study of multivisceral resection for retroperitoneal sarcoma: clinical and patient-reported outcomes 1 Year after surgery","volume":"28","author":"Fiore","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2022.04.020_bib58","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/jso.25337","article-title":"Completion surgery of residual disease after primary inadequate surgery of retroperitoneal sarcomas can salvage a selected subgroup of patients-A propensity score analysis","volume":"119","author":"Nizri","year":"2019","journal-title":"J\u00a0Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2022.04.020_bib59","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1245\/s10434-016-5523-6","article-title":"Results of resection for recurrent or residual retroperitoneal sarcoma after failed primary treatment","volume":"24","author":"Hamilton","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2022.04.020_bib60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jso.24892","article-title":"Radiation therapy in retroperitoneal sarcoma management","volume":"117","author":"Haas","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2022.04.020_bib61","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/annonc\/mds516","article-title":"Should adjuvant radiotherapy be administered in addition to front-line aggressive surgery (FAS) in patients with primary retroperitoneal sarcoma?","volume":"24","author":"Le P\u00e9choux","year":"2013","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2022.04.020_bib62","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ejso.2018.02.001","article-title":"Neoadjuvant and adjuvant strategies in retroperitoneal sarcoma","volume":"44","author":"Almond","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2022.04.020_bib63","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF02573869","article-title":"Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma","volume":"9","author":"Jones","year":"2002","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2022.04.020_bib64","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/SLA.0000000000000840","article-title":"Long-term oncologic outcomes after neoadjuvant radiation therapy for retroperitoneal sarcomas","volume":"262","author":"Nussbaum","year":"2015","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.ejso.2022.04.020_bib65","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S1470-2045(16)30050-X","article-title":"Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database","volume":"17","author":"Nussbaum","year":"2016","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2022.04.020_bib66","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/cncr.31927","article-title":"Radiotherapy for retroperitoneal liposarcoma: a report from the transatlantic retroperitoneal sarcoma working group","volume":"125","author":"Haas","year":"2019","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2022.04.020_bib67","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/cncr.23592","article-title":"A\u00a0systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma","volume":"113","author":"Pervaiz","year":"2008","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.ejso.2022.04.020_bib68","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1470-2045(12)70346-7","volume":"13","author":"Woll","year":"2012","journal-title":"Lancet Oncol"},{"issue":"13","key":"10.1016\/j.ejso.2022.04.020_bib69","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1245\/s10434-017-6105-y","article-title":"Long-term follow-up and post-relapse outcome of patients with localized retroperitoneal sarcoma treated in the Italian sarcoma group-soft tissue sarcoma (ISG-STS) protocol 0303","volume":"24","author":"De Sanctis","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2022.04.020_bib70","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1470-2045(10)70071-1","volume":"11","author":"Issels","year":"2010","journal-title":"Lancet Oncol"},{"issue":"19","key":"10.1016\/j.ejso.2022.04.020_bib71","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1200\/JCO.2000.18.19.3378","article-title":"Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas","volume":"18","author":"Meric","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2022.04.020_bib72","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1245\/s10434-014-3616-7","article-title":"A\u00a0contemporary large single-institution evaluation of resected retroperitoneal sarcoma","volume":"21","author":"Bremjit","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2022.04.020_bib73","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ejca.2013.11.021","article-title":"Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: a phase I-II study from the Italian Sarcoma Group","volume":"50","author":"Gronchi","year":"2014","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2022.04.020_bib74","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13063-021-05069-z","article-title":"Neoadjuvant irradiation of retroperitoneal soft tissue sarcoma with ions (Retro-Ion): study protocol for a randomized phase II pilot trial","volume":"22","author":"Seidensaal","year":"2021","journal-title":"Trials"},{"issue":"4","key":"10.1016\/j.ejso.2022.04.020_bib75","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1470-2045(14)70063-4","article-title":"European Organisation and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial","volume":"15","author":"Judson","year":"2014","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2022.04.020_bib76","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S1470-2045(17)30334-0","article-title":"Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial","volume":"18","author":"Gronchi","year":"2017","journal-title":"Lancet Oncol"},{"issue":"19","key":"10.1016\/j.ejso.2022.04.020_bib77","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1200\/JCO.19.03289","article-title":"Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: final results of a randomized trial from Italian (ISG), Spanish (GEIS), French (FSG), and polish (PSG) sarcoma groups","volume":"38","author":"Gronchi","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2022.04.020_bib78","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1002\/cncr.32795","volume":"126","author":"D'Ambrosio","year":"2020","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.ejso.2022.04.020_bib79","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/cncr.25057","article-title":"Histology-specific nomogram for primary retroperitoneal soft tissue sarcoma","volume":"116","author":"Ardoino","year":"2010","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2022.04.020_bib80","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/annonc\/mdp298","article-title":"Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent","volume":"21","author":"Anaya","year":"2010","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2022.04.020_bib81","doi-asserted-by":"crossref","first-page":"7854","DOI":"10.1245\/s10434-021-10024-y","article-title":"Analysis of differentiation changes and outcomes at time of first recurrence of retroperitoneal liposarcoma by transatlantic Australasian retroperitoneal sarcoma working group (TARPSWG)","volume":"28","author":"Nessim","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2022.04.020_bib82","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1245\/s10434-020-09445-y","article-title":"Postoperative morbidity after resection of recurrent retroperitoneal sarcoma: a report from the transatlantic Australasian RPS working group (TARPSWG)","volume":"28","author":"Nessim","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2022.04.020_bib83","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/SLA.0b013e3181b2468b","article-title":"Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule","volume":"250","author":"Park","year":"2009","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2022.04.020_bib86","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clon.2014.09.010","article-title":"Groupe Sarcome Francais-Groupe D'etude Des Tumeurs Osseuses. Effect on survival of local ablative treatment of metastases from sarcomas: a study of the French sarcoma group","volume":"27","author":"Falk","year":"2015","journal-title":"Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2022.04.020_bib85","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jamcollsurg.2011.01.007","article-title":"Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients","volume":"212","author":"Stephens","year":"2011","journal-title":"J\u00a0Am Coll Surg"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322004176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322004176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:47:19Z","timestamp":1760060839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798322004176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":85,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0748798322004176"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2022.04.020","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to treat liposarcomas located in retroperitoneum","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2022.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}